Interferon-gamma release assays should not replace tuberculin skin tests in screening programs for children

Pediatric Infectious Disease Journal

Volumn 35, Issue 8, 2016, Pages 929-

  Tebruegge, Marc ^a,b,c   Clifford, Vanessa ^c,d   Curtis, Nigel ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINATION; CHILD; HUMAN; IMMIGRATION; INTERFERON GAMMA RELEASE ASSAY; LETTER; PRIORITY JOURNAL; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; MASS SCREENING;

GAMMA INTERFERON;

CHILD; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; MASS SCREENING; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84979547541     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001195     Document Type: Letter

References (11)

1. Lowenthal P, Barry PM, Flood J. High discordance between pre- And post-U.S. entry tuberculosis test results among immigrant children: is it time to adopt interferon gamma release assay for pre-entry tuberculosis screening? Pediatr Infect Dis J. 2015; 35: 231-236.
2. Tebruegge M, Ritz N, Curtis N, et al. Diagnostic tests for childhood tuberculosis: past imperfect, present tense and future perfect? Pediatr Infect Dis J. 2015 34 1014-1019.
3. Farhat M, Greenaway C, Pai M, et al. Falsepositive tuberculin skin tests: what is the absolute effect of BCG and non-Tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006 10 1192-1204.
4. Tebruegge M, Pantazidou A, McGregor D, et al. Nontuberculous mycobacterial disease- epidemiology, diagnosis and management in a large pediatric cohort at a tertiary referral center. PLoS ONE. 2016; 11: e0147513.
5. Tebruegge M, Dutta B, Donath S, et al. Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis. Am J Respir Crit Care Med. 2015; 192: 485-499.
6. Tebruegge M, Ritz N, Koetz K, et al. Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in Europe. PLoS One. 2014; 9: e99129.
7. Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014; 27: 3-20.
8. Jarvis J, Gao Y, de Graaf H, et al. Environmental temperature impacts on the performance of QuantiFERON-TB Gold In-Tube assays. J Infect. 2015; 71: 276-280.
9. Tebruegge M, de Graaf H, Sukhtankar P, et al. Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results. J Clin Microbiol. 2014; 52: 2694-2697.
10. Starke JR; Committee On Infectious Diseases. Interferon-? release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics. 2014; 134: e1763-e1773.
11. Stop TB Partnership. Global plan to end TB 2016-2020. Available at: www.stoptb.org/.global/plan/plan2/. Accessed December 17, 2015.